Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Mederacke, Ingmar, Hsu, Christine C., Troeger, Juliane S., Huebener, Peter, Mu, Xueru, Dapito, Dianne H., Pradere, Jean-Philippe, Schwabe, Robert F.·2013·Nature Communications

Cited by (1,001)

Items 101–200 of 1,001

  1. Cellular and molecular mechanisms in liver fibrogenesis
    Erica Novo, Stefania Cannito, Claudia Paternostro, Claudia Bocca, Antonella Miglietta, Maurizio Parola · 2014 · Archives of Biochemistry and Biophysics
  2. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis
    Matsuda, Michitaka, Seki, Ekihiro · 2020 · Seminars in Liver Disease
  3. β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis
    Peri Kocabayoglu, Abigale G. Lade, Youngmin A. Lee, Ana-Cristina Dragomir, Xiaochen Sun, Maria Isabel Fiel, Swan N. Thung, Costica Aloman, Philippe M. Soriano, Yujin Hoshida et al. · 2015 · Journal of Hepatology
  4. Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis
    Satoshi Ueha, Francis H. W. Shand, Kouji Matsushima · 2012 · Frontiers in Immunology
  5. Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents
    Katrin Böttcher, Massimo Pinzani · 2017 · Advanced Drug Delivery Reviews
  6. Extracellular Matrix Remodeling in Chronic Liver Disease
    Cristina Ortiz, Robert Schierwagen, Liliana Schaefer, Sabine Klein, Xavier Trepat, Jonel Trebicka · 2021 · Current Tissue Microenvironment Reports
  7. Pericytes, mesenchymal stem cells and their contributions to tissue repair
    Suet‐Ping Wong, Jessica E. Rowley, Andia N. Redpath, Jessica Tilman, Tariq G. Fellous, Jill R. Johnson · 2015 · Pharmacology & Therapeutics
  8. Pathophysiological mechanisms underlying MAFLD
    Mohammad Shafi Kuchay, Narendra Singh Choudhary, Sunil Kumar Mishra · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  9. Inflammasomes in liver fibrosis
    Alegre, Fernando, Pelegrin, Pablo, Feldstein, Ariel · 2017 · Seminars in Liver Disease
  10. FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxis
    Lachowski, Dariusz, Cortes, Ernesto, Robinson, Benjamin, Rice, Alistair, Rombouts, Krista, Del Río Hernández, Armando E. · 2018 · The FASEB Journal
  11. Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma
    Yamagishi, Ryota, Kamachi, Fumitaka, Nakamura, Masaru, Yamazaki, Shota, Kamiya, Tomonori, Takasugi, Masaki, Cheng, Yi, Nonaka, Yoshiki, Yukawa-Muto, Yoshimi, Thuy, Le Thi Thanh et al. · 2022 · Science Immunology
  12. Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
    Bénédicte Delire, Peter Stärkel, Isabelle Anne Leclercq · 2015 · Journal of Clinical and Translational Hepatology
  13. Hepatic stellate cells contribute to progenitor cells and liver regeneration
    Claus Kordes, Iris Sawitza, Silke Götze, Diran Herebıan, Dieter Häussinger · 2014 · Journal of Clinical Investigation
  14. Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis
    Matthew Decker, Leticia Martínez-Morentin, Guannan Wang, Yeojin Lee, Qingxue Liu, Juliana S. Leslie, Lei Ding · 2017 · Nature Cell Biology
  15. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy
    Xuanyan Cai, Jiajia Wang, Jincheng Wang, Qian Zhou, Bo Yang, Qiaojun He, Qinjie Weng · 2020 · Pharmacological Research
  16. Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis
    Yang, Yoon Mee, Noureddin, Mazen, Liu, Cheng, Ohashi, Koichiro, Kim, So Yeon, Ramnath, Divya, Powell, Elizabeth E., Sweet, Matthew J., Roh, Yoon Seok, Hsin, I-Fang et al. · 2019 · Science Translational Medicine
  17. The perivascular origin of pathological fibroblasts
    Di Carlo, Selene E., Peduto, Lucie · 2018 · Journal of Clinical Investigation
  18. Hepatic stellate cell activation and pro-fibrogenic signals
    Chandrashekhar R. Gandhi · 2017 · Journal of Hepatology
  19. Epithelial–mesenchymal transition in tissue repair and degeneration
    Khalil Kass Youssef, Maria Angela Nieto · 2024 · Nature Reviews Molecular Cell Biology
  20. Liver Sinusoidal Endothelial Cell: An Update
    Ana Claudia Maretti-Mira, Laurie D. DeLeve · 2017 · Seminars in Liver Disease
  21. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling
    Chaojie Chen, Jiajun Chen, Ying Wang, Liu Fang, Cuiling Guo, Tingting Sang, He Peng, Qian Zhao, Shengjia Chen, Xiaojian Lin et al. · 2022 · Phytomedicine
  22. Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity
    Payen, Valéry L., Lavergne, Arnaud, Alevra Sarika, Niki, Colonval, Megan, Karim, Latifa, Deckers, Manon, Najimi, Mustapha, Coppieters, Wouter, Charloteaux, Benoît, Sokal, Etienne M. et al. · 2021 · JHEP Reports
  23. Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
    Wang, Shuang, Friedman, Scott L. · 2023 · Science Translational Medicine
  24. Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells
    Jinhang Zhang, Yanping Li, Qinhui Liu, Ya Huang, Rui Li, Tong Wu, Zijing Zhang, Jian Zhou, Hui Huang, Qin Tang et al. · 2020 · Hepatology
  25. S100A4 promotes liver fibrosis via activation of hepatic stellate cells
    Lin Chen, Jie Li, Jinhua Zhang, Chengliang Dai, Xiaoman Liu, Jun Wang, Zhitao Gao, Hongyan Guo, Rui Wang, Shichun Lu et al. · 2014 · Journal of Hepatology
  26. Friend or foe? The elusive role of hepatic stellate cells in liver cancer
    Bruno Cogliati, Chittampalli N. Yashaswini, Shuang Wang, Daniela Sia, Scott L. Friedman · 2023 · Nature Reviews Gastroenterology & Hepatology
  27. Genetics of primary sclerosing cholangitis and pathophysiological implications
    Jiang, Xiaojun, Karlsen, Tom H. · 2017 · Nature Reviews Gastroenterology & Hepatology
  28. 3D in vitro models of liver fibrosis
    Leo A. van Grunsven · 2017 · Advanced Drug Delivery Reviews
  29. Sphingosine kinase 1 promotes liver fibrosis by preventing miR‐19b‐3p‐mediated inhibition of CCR2
    Lan, Tian, Li, Changzheng, Yang, Guizhi, Sun, Yue, Zhuang, Lihang, Ou, Yitao, Li, Hui, Wang, Genshu, Kisseleva, Tatiana, Brenner, David et al. · 2018 · Hepatology
  30. Angiogenesis and Fibrogenesis in Chronic Liver Diseases
    Claudia Bocca, Erica Novo, Antonella Miglietta, Maurizio Parola · 2015 · Cellular and Molecular Gastroenterology and Hepatology
  31. Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers
    Ingrid Lua, Yuchang Li, Jessica Aya Zagory, Kasper S. Wang, Samuel William French, Jean Sévigny, Kinji Asahina · 2016 · Journal of Hepatology
  32. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma
    Juling Ji, Tobias Eggert, Anuradha Budhu, Marshonna Forgues, Atsushi Takai, Hien T. Dang, Qing‐Hai Ye, Ju‐Seog Lee, Ji Hoon Kim, Tim F. Greten et al. · 2015 · Hepatology
  33. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation
    Cristina Bárcena, Milica Stefanović, Anna Tutusaus, Leonel D. Joannas, Anghara Menéndez, Carmen García‐Ruiz, Pau Sancho‐Bru, Montserrat Marı́, Joan Caballería, Carla Vanina Rothlin et al. · 2015 · Journal of Hepatology
  34. Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis
    Dariusz Lachowski, Ernesto Cortés, Alistair J. Rice, David James Pinato, Krista Rombouts, Armando E. del Río Hernández · 2019 · Scientific Reports
  35. In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis
    Rezvani, Milad, Español-Suñer, Regina, Malato, Yann, Dumont, Laure, Grimm, Andrew A., Kienle, Eike, Bindman, Jay G., Wiedtke, Ellen, Hsu, Bernadette Y., Naqvi, Syed J. et al. · 2016 · Cell Stem Cell
  36. A human multi-lineage hepatic organoid model for liver fibrosis
    Guan, Yuan, Enejder, Annika, Wang, Meiyue, Fang, Zhuoqing, Cui, Lu, Chen, Shih-Yu, Wang, Jingxiao, Tan, Yalun, Wu, Manhong, Chen, Xinyu et al. · 2021 · Nature Communications
  37. NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice
    Inzaugarat, Maria Eugenia, Johnson, Casey D., Holtmann, Theresa Maria, McGeough, Matthew D., Trautwein, Christian, Papouchado, Bettina G., Schwabe, Robert, Hoffman, Hal M., Wree, Alexander, Feldstein, Ariel E. · 2019 · Hepatology
  38. Multipotent stromal cells: One name, multiple identities
    Soliman, Hesham, Theret, Marine, Scott, Wilder, Hill, Lesley, Underhill, Tully Michael, Hinz, Boris, Rossi, Fabio M.V. · 2021 · Cell Stem Cell
  39. Heterogeneity of HSCs in a Mouse Model of NASH
    Rosenthal, Sara Brin, Liu, Xiao, Ganguly, Souradipta, Dhar, Debanjan, Pasillas, Martina P., Ricciardelli, Eugenia, Li, Rick Z., Troutman, Ty D., Kisseleva, Tatiana, Glass, Christopher K. et al. · 2021 · Hepatology
  40. Therapeutic targeting of liver inflammation and fibrosis by nanomedicine.
    Matthias Bartneck, Klaudia Theresa Warzecha, Frank Tacke · 2014 · Europe PMC (PubMed Central)
  41. Evolving Roles of Muscle-Resident Fibro-Adipogenic Progenitors in Health, Regeneration, Neuromuscular Disorders, and Aging
    M. Théret, F. Rossi, Osvaldo Contreras · 2021 · Frontiers in Physiology
  42. Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators
    Lijun Chen, Chunfeng Zhang, Lu Chen, Xiaojun Wang, Bingyu Xiang, Xiaoxing Wu, Yang Guo, Xiaozhou Mou, Li Yuan, Bo Chen et al. · 2016 · Stem Cells Translational Medicine
  43. Keloid disorder: Fibroblast differentiation and gene expression profile in fibrotic skin diseases
    Edward J. Macarak, Peter J. Wermuth, Joel Rosenbloom, Jouni Uitto · 2020 · Experimental Dermatology
  44. HK1 from hepatic stellate cell–derived extracellular vesicles promotes progression of hepatocellular carcinoma
    Qi-Tao Chen, Zhiyuan Zhang, Qiaoling Huang, Hang‐zi Chen, Wenbin Hong, Tianwei Lin, Wenxiu Zhao, Xiaomin Wang, Cui-yu Ju, Liu-zheng Wu et al. · 2022 · Nature Metabolism
  45. Hepatocyte-Macrophage Acetoacetate Shuttle Protects Against Tissue Fibrosis
    Puchalska, Patrycja, Martin, Shannon E., Huang, Xiaojing, Lengfeld, Justin E., Daniel, Bence, Graham, Mark J., Han, Xianlin, Nagy, Laszlo, Patti, Gary J., Crawford, Peter A. · 2019 · Cell Metabolism
  46. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice
    Takahiro Nishio, Ronglin Hu, Yukinori Koyama, Shuang Liang, Sara B. Rosenthal, Gen Yamamoto, Daniel Karin, Jacopo Baglieri, Hsiao‐Yen Ma, Jun Xu et al. · 2019 · Journal of Hepatology
  47. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis
    Daniel Karin, Yukinori Koyama, David A. Brenner, Tatiana Kisseleva · 2016 · Differentiation
  48. Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape
    Agata Page, Pier P. Paoli, Eva Moran Salvador, Steven A White, Jeremy French, Jelena Mann · 2015 · Journal of Hepatology
  49. Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy
    Deniz Seyhan, Manon Allaire, Yaojie Fu, Filoména Conti, Xin Wei Wang, Bin Gao, Fouad Lafdil · 2025 · Cellular and Molecular Immunology
  50. Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
    Mengying Hu, Ying Wang, Ligeng Xu, Sai An, Yu Tang, Xuefei Zhou, Jingjing Li, Rihe Liu, Leaf Huang · 2019 · Nature Communications
  51. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
    Kook Hwan Kim, Seong‐Hun Kim, Dai Hoon Han, Young Suk Jo, Yong‐ho Lee, Myung‐Shik Lee · 2018 · Scientific Reports
  52. Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis
    Xueke Zhao, Lei Yu, Mingliang Cheng, Pulin Che, Yinying Lu, Quan Zhang, Mao Mu, Hong Li, Li-Li Zhu, Juanjuan Zhu et al. · 2017 · Scientific Reports
  53. Danger signals in liver injury and restoration of homeostasis
    Han, Hui, Desert, Romain, Das, Sukanta, Song, Zhuolun, Athavale, Dipti, Ge, Xiaodong, Nieto, Natalia · 2020 · Journal of Hepatology
  54. Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles
    Sara Lemoinne, Axelle Cadoret, Pierre‐Emmanuel Rautou, Haquima El Mourabit, Vlad Ratziu, Christophe Corpechot, Colette Rey, Nelly Bosselut, Véronique Barbu, Dominique Wendum et al. · 2014 · Hepatology
  55. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies
    Jun Xu, Xiao Liu, Yukinori Koyama, Ping Wang, Tian Lan, In‐Gyu Kim, In H. Kim, Hsiao‐Yen Ma, Tatiana Kisseleva · 2014 · Frontiers in Pharmacology
  56. Human hepatic stellate cell isolation and characterization
    Linshan Shang, Mojgan Hosseini, Xiao Liu, Tatiana Kisseleva, David A. Brenner · 2017 · Journal of Gastroenterology
  57. Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol
    Ming Jun Yang, Xiaoqiang Qi, Nan Li, Jussuf T. Kaifi, Shi‐You Chen, Andrew A. Wheeler, Eric T. Kimchi, Aaron C. Ericsson, R. Scott Rector, Kevin F. Staveley-O’Carroll et al. · 2023 · Nature Communications
  58. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis
    Yan Jiang, Chan Xiang, Fan Zhong, Yang Zhang, Liyan Wang, Yuanyuan Zhao, Jiucun Wang, Chen Ding, Jin Li, Fuchu He et al. · 2020 · Theranostics
  59. Kupffer cell–like syncytia replenish resident macrophage function in the fibrotic liver
    Peiseler, Moritz, Araujo David, Bruna, Zindel, Joel, Surewaard, Bas G. J., Lee, Woo-Yong, Heymann, Felix, Nusse, Ysbrand, Castanheira, Fernanda V. S., Shim, Raymond, Guillot, Adrien et al. · 2023 · Science
  60. Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice
    Alsamman, Sarah, Christenson, Stephanie A., Yu, Amy, Ayad, Nadia M. E., Mooring, Meghan S., Segal, Joe M., Hu, Jimmy Kuang-Hsien, Schaub, Johanna R., Ho, Steve S., Rao, Vikram et al. · 2020 · Science Translational Medicine
  61. Cirrhosis: A Questioned Risk Factor for Hepatocellular Carcinoma
    Amanda Garrido, Nabil Djouder · 2020 · Trends in cancer
  62. Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment
    Yang, Xue, Li, Qing, Liu, Wenting, Zong, Chen, Wei, Lixin, Shi, Yufang, Han, Zhipeng · 2023 · Cellular & Molecular Immunology
  63. Novel therapeutic targets in primary biliary cirrhosis
    Dyson, Jessica K., Hirschfield, Gideon M., Adams, David H., Beuers, Ulrich, Mann, Derek A., Lindor, Keith D., Jones, David E. J. · 2015 · Nature Reviews Gastroenterology & Hepatology
  64. Novel mechanisms and clinical trial endpoints in intestinal fibrosis*
    Jie Wang, Sinan Lin, Jonathan Mark Brown, David R. Van Wagoner, Claudio Fiocchi, Florian Rieder · 2021 · Immunological Reviews
  65. Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin
    Lefebvre, Philippe, Lalloyer, Fanny, Baugé, Eric, Pawlak, Michal, Gheeraert, Céline, Dehondt, Hélène, Vanhoutte, Jonathan, Woitrain, Eloise, Hennuyer, Nathalie, Mazuy, Claire et al. · 2017 · JCI Insight
  66. Understanding the cellular interactome of non-alcoholic fatty liver disease
    Wallace, Sebastian J., Tacke, Frank, Schwabe, Robert F., Henderson, Neil C. · 2022 · JHEP Reports
  67. Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis
    Savage, Thomas M., Fortson, Katherine T., de los Santos-Alexis, Kenia, Oliveras-Alsina, Angelica, Rouanne, Mathieu, Rae, Sarah S., Gamarra, Jennifer R., Shayya, Hani, Kornberg, Adam, Cavero, Renzo et al. · 2024 · Immunity
  68. Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model
    Sook In Chung, Hyuk Moon, Hye-Lim Ju, Kyung Joo Cho, Do Young Kim, Kwang‐Hyub Han, Jung Woo Eun, Suk Woo Nam, Silvia Ribback, Frank Dombrowski et al. · 2015 · Journal of Hepatology
  69. Functional Immune Anatomy of the Liver—As an Allograft
    Anthony J. Demetris, Christopher O.C. Bellamy, C.R. Gandhi, Sandrine Prost, Yasuni Nakanuma, D.B. Stolz · 2016 · American Journal of Transplantation
  70. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice
    Jingxiao Wang, Mingjie Dong, Zhong Xu, Xinhua Song, Shanshan Zhang, Yu Qiao, Li Che, John Dozier Gordan, Kaiwen Hu, Yan Liu et al. · 2018 · Oncogene
  71. Curcumin Attenuates Lipopolysaccharide‐Induced Hepatic Lipid Metabolism Disorder by Modification of m6A RNA Methylation in Piglets
    Na Lü, Xingmei Li, Jiayao Yu, Yi Li, Chao Wang, Lili Zhang, Tian Wang, Xiang Zhong · 2018 · Lipids
  72. TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives
    Serena Mancarella, Antonio Cigliano, Annarita Chieti, Gianluigi Giannelli, Francesco Dituri · 2018 · Seminars in Liver Disease
  73. Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin
    Qin, Lei, Liu, Nian, Bao, Chao-le-meng, Yang, Da-zhi, Ma, Gui-xing, Yi, Wei-hong, Xiao, Guo-zhi, Cao, Hui-ling · 2023 · Acta Pharmacologica Sinica
  74. Tissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapies
    Dario Ruben Lemos, Jeremy S. Duffield · 2018 · Science Translational Medicine
  75. Liver progenitor cell-driven liver regeneration
    Juhoon So, Angie S. Kim, Seung‐Hoon Lee, Donghun Shin · 2020 · Experimental & Molecular Medicine
  76. Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC
    Yujia Xia, Yu Wang, Qi Xiong, Jiayi He, Han Wang, Mozaffarul Islam, Xinyu Zhou, Alex C. Kim, Hongji Zhang, Hai Huang et al. · 2024 · Hepatology
  77. Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis
    Zhu, Changyu, Tabas, Ira, Schwabe, Robert F., Pajvani, Utpal B. · 2021 · Nature Reviews Gastroenterology & Hepatology
  78. Hepatic stellate cells: balancing homeostasis, hepatoprotection and fibrogenesis in health and disease
    Schwabe, Robert F., Brenner, David A. · 2025 · Nature Reviews Gastroenterology & Hepatology
  79. The Carcinogenic Role of the Notch Signaling Pathway in the Development of Hepatocellular Carcinoma
    Qinfeng Huang, Junhong Li, Jinghui Zheng, Ailing Wei · 2019 · Journal of Cancer
  80. Differential contribution of pancreatic fibroblast subsets to the pancreatic cancer stroma
    Garcia, Paloma E., Adoumie, Maeva, Kim, Esther C., Zhang, Yaqing, Scales, Michael K., El-Tawil, Yara S., Shaikh, Amara Z., Wen, Hui-Ju, Bednar, Filip, Allen, Ben L. et al. · 2020 · Cellular and Molecular Gastroenterology and Hepatology
  81. Hepatic stellate cells control liver zonation, size and functions via R-spondin 3
    Sugimoto, Atsushi, Saito, Yoshinobu, Wang, Guanxiong, Sun, Qiuyan, Yin, Chuan, Lee, Ki Hong, Geng, Yana, Rajbhandari, Presha, Hernandez, Celine, Steffani, Marcella et al. · 2025 · Nature
  82. Intracellular Glutathione Depletion by Oridonin Leads to Apoptosis in Hepatic Stellate Cells
    Liang Mou Kuo, Chan‐Yen Kuo, Chen Yu Lin, Min-Fa Hung, Jiann Jong Shen, Tsong‐Long Hwang · 2014 · Molecules
  83. The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability
    Arya Mariam Roy, Renuka V. Iyer, Sayan Chakraborty · 2023 · Cell Reports Medicine
  84. Liver stem cells: experimental findings and implications for human liver disease
    Michalopoulos, George K., Khan, Zahida · 2015 · Gastroenterology
  85. Asiatic acid attenuates CCl 4 -induced liver fibrosis in rats by regulating the PI3K/AKT/mTOR and Bcl-2/Bax signaling pathways
    Liwen Wei, Qingshan Chen, Aijie Guo, Jie Fan, Rong Wang, Hai Zhang · 2018 · International Immunopharmacology
  86. Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice
    Jiong Yan, Hung‐Chun Tung, Sihan Li, Yongdong Niu, Wojciech G. Garbacz, Peipei Lu, Yuhan Bi, Yanping Li, Jinhan He, Meishu Xu et al. · 2019 · Gastroenterology
  87. The Portal Fibroblast: Not Just a Poor Man's Stellate Cell
    Rebecca G. Wells · 2014 · Gastroenterology
  88. Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny
    Jianpeng Sheng, Junlei Zhang, Lin Wang, Vincent Tano, Jianghui Tang, Xun Wang, Jiangchao Wu, Jinyuan Song, Yaxing Zhao, Jingxia Rong et al. · 2021 · Gut
  89. Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways
    Qingshan Chen, Hai Zhang, Yan Wei Cao, Ying Li, Sen Sun, Junping Zhang, Guoqing Zhang · 2017 · Drug Design Development and Therapy
  90. Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis
    Marcos F. Fondevila, Uxia Fernandez, Violeta Heras, Tamara Parracho, María J. Gonzalez-Rellan, Eva Nóvoa, Begoña Porteiro, Cristina Alonso, Rebeca Mayo, Natália da Silva Lima et al. · 2022 · Journal of Hepatology
  91. Transcriptional Dynamics of Hepatic Sinusoid‐Associated Cells After Liver Injury
    Mike Krogh Terkelsen, Sofie Marchsteiner Bendixen, Daniel Hansen, Emma A.H. Scott, Andreas F. Moeller, Ronni Nielsen, Susanne Mandrup, Anders Grønnegaard Schlosser, Thomas Levin Andersen, Grith Lykke Sørensen et al. · 2020 · Hepatology
  92. The innate immune receptor TREM-1 promotes liver injury and fibrosis
    Nguyen-Lefebvre, Anh Thu, Ajith, Ashwin, Portik-Dobos, Vera, Horuzsko, Daniel David, Arbab, Ali Syed, Dzutsev, Amiran, Sadek, Ramses, Trinchieri, Giorgio, Horuzsko, Anatolij · 2018 · Journal of Clinical Investigation
  93. The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver
    Mederacke, Ingmar, Filliol, Aveline, Affo, Silvia, Nair, Ajay, Hernandez, Celine, Sun, Qiuyan, Hamberger, Florian, Brundu, Francesco, Chen, Yu, Ravichandra, Aashreya et al. · 2022 · Science Translational Medicine
  94. Hepatic stellate cells: central modulators of hepatic carcinogenesis
    Alexandra Thompson, Kylie P. Conroy, Neil Cowan Henderson · 2015 · BMC Gastroenterology
  95. Stellate Cells in Tissue Repair, Inflammation, and Cancer
    Mara H. Sherman · 2018 · Annual Review of Cell and Developmental Biology
  96. Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
    Liteng Lin, Hengye Gong, Rui Li, Jingjun Huang, Mingyue Cai, Tian Lan, Wensou Huang, Yongjian Guo, Zhimei Zhou, Yongcheng An et al. · 2020 · Advanced Science
  97. Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions
    Kaffe, Eleanna, Roulis, Manolis, Zhao, Jun, Qu, Rihao, Sefik, Esen, Mirza, Haris, Zhou, Jing, Zheng, Yunjiang, Charkoftaki, Georgia, Vasiliou, Vasilis et al. · 2023 · Cell
  98. Pathogenesis of Wilson disease
    Ivo Florin Scheiber, Radan Brůha, Petr Dušek · 2017 · Handbook of clinical neurology
  99. Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells
    2025
  100. Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations
    Marica Cariello, Elena Piccinin, Oihane García‐Irigoyen, Carlo Sabbà, Antonio Moschetta · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease